|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bellissimo F, Pinzone MR, Cacopardo B and
Nunnari G: Diagnostic and therapeutic management of hepatocellular
carcinoma. World J Gastroenterol. 21:12003–12021. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng D, Deng J, Zhang B, He X, Meng Z, Li
G, Ye H, Zheng S, Wei L, Deng X, et al: LncRNA HOTAIR
epigenetically suppresses miR-122 expression in hepatocellular
carcinoma via DNA methylation. EBioMedicine. 36:159–170. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lou W, Liu J, Gao Y, Zhong G, Ding B, Xu L
and Fan W: MicroRNA regulation of liver cancer stem cells. Am J
Cancer Res. 8:1126–1141. 2018.PubMed/NCBI
|
|
5
|
Huang Z, Zhou JK, Peng Y, He W and Huang
C: The role of long noncoding RNAs in hepatocellular carcinoma. Mol
Cancer. (19): 772020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gong D, Feng PC, Ke X-F, Kuang HL, Pan LL,
Ye Q and Wu JB: Silencing long non-coding RNA LINC01224 inhibits
hepatocellular carcinoma progression via MicroRNA-330-5p-induced
inhibition of CHEK1. Mol Ther Nucleic Acids. 19:482–497. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jia M, Jiang L, Wang YD, Huang JZ, Yu M
and Xue HZ: LincRNA-p21 inhibits invasion and metastasis of
hepatocellular carcinoma through Notch signaling induced
epithelial-mesenchymal transition. Hepatol Res. 46:1137–1144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu F, Yuan JH, Huang JF, Yang F, Wang TT,
Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA
FTX inhibits hepatocellular carcinoma proliferation and metastasis
by binding MCM2 and miR-374a. Oncogene. 35:5422–5434. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang CZ, Yan GX, Dong DS, Xin H and Liu
ZY: LncRNA-ATB promotes autophagy by activating Yes-associated
protein and inducing autophagy-related protein 5 expression in
hepatocellular carcinoma. World J Gastroenterol. 25:5310–5322.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marx S, Dal Maso T, Chen JW, Bury M,
Wouters J, Michiels C and Le Calvé B: Transmembrane (TMEM) protein
family members: Poorly characterized even if essential for the
metastatic process. Semin Cancer Biol. 60:96–106. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J and Zhu H: TMEM106A inhibits cell
proliferation, migration, and induces apoptosis of lung cancer
cells. J Cell Biochem. Nov 19–2018.(Epub ahead of print). doi:
10.1002/jcb.28057.
|
|
12
|
Lang CM, Fellerer K, Schwenk BM, Kuhn PH,
Kremmer E, Edbauer D, Capell A and Haass C: Membrane orientation
and subcellular localization of transmembrane protein 106B
(TMEM106B), a major risk factor for frontotemporal lobar
degeneration. J Biol Chem. 287:19355–19365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Assassi S, Reveille JD, Arnett FC, Weisman
MH, Ward MM, Agarwal SK, Gourh P, Bhula J, Sharif R, Sampat K, et
al: Whole-blood gene expression profiling in ankylosing spondylitis
shows upregulation of toll-like receptor 4 and 5. J Rheumatol.
38:87–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo X, Han G, Lu R, Guan S, Wang Y, Ju L,
Chen L, Shao J and Bian Z: Transmembrane protein 106C promotes the
development of hepatocellular carcinoma. J Cell Biochem.
121:4484–4495. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Therneau TM: Survival Analysis [R package
survival version 2.39-5]. 46:111–112. 2015.
|
|
17
|
R Core Team: A Language And Environment
For Statistical Computing. R Foundation for Statistical Computing;
Vienna: 2012
|
|
18
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The Molecular Signatures
Database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Ma W, Zeng P, Wang J, Geng B, Yang J
and Cui Q: LncTar: A tool for predicting the RNA targets of long
noncoding RNAs. Brief Bioinform. 16:806–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mo Y, He L, Lai Z, Wan Z, Chen Q, Pan S,
Li L, Li D, Huang J, Xue F, et al: LINC01287/miR-298/STAT3 feedback
loop regulates growth and the epithelial-to-mesenchymal transition
phenotype in hepatocellular carcinoma cells. J Exp Clin Cancer Res.
37:149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu S, Huang X, Zhang K, Tan W, Lin Z, He
Q, Chen Y and Shang C: Low expression of long noncoding RNA
CTC-297N7.9 predicts poor prognosis in patients with hepatocellular
carcinoma. Cancer Med. 8:7679–7692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duan J, Qian Y, Fu X, Chen M, Liu K, Liu
H, Yang J, Liu C and Chang Y: TMEM106C contributes to the malignant
characteristics and poor prognosis of hepatocellular carcinoma.
Aging (Albany NY). 13:5585–5606. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hai T, Wolford CC and Chang YS: ATF3, a
hub of the cellular adaptive-response network, in the pathogenesis
of diseases: Is modulation of inflammation a unifying component?
Gene Expr. 15:1–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yan C and Boyd DD: ATF3 regulates the
stability of p53: A link to cancer. Cell Cycle. 5:926–929. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Yang Z, Chen Z, Bao Y, Zhang H, Fang
X and Yang W: ATF3 suppresses ESCC via downregulation of ID1. Oncol
Lett. 12:1642–1648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hackl C, Lang SA, Moser C, Mori A,
Fichtner-Feigl S, Hellerbrand C, Dietmeier W, Schlitt HJ, Geissler
EK and Stoeltzing O: Activating transcription factor-3 (ATF3)
functions as a tumor suppressor in colon cancer and is up-regulated
upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer.
10:6682010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv L, Wei M, Lin P, Chen Z, Gong P, Quan Z
and Tang Z: Integrated mRNA and lncRNA expression profiling for
exploring metastatic biomarkers of human intrahepatic
cholangiocarcinoma. Am J Cancer Res. 7:688–699. 2017.PubMed/NCBI
|
|
30
|
Reed JC: Mechanisms of apoptosis avoidance
in cancer. Curr Opin Oncol. 11:68–75. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi TY, He J, Wang MY, Zhu ML, Yu KD, Shao
ZM, Sun MH, Wu X, Cheng X and Wei Q: CASP7 variants modify
susceptibility to cervical cancer in Chinese women. Sci Rep.
5:9225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Palmerini F, Devilard E, Jarry A, Birg F
and Xerri L: Caspase 7 downregulation as an immunohistochemical
marker of colonic carcinoma. Hum Pathol. 32:461–467. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peeney D, Jensen SM, Castro NP, Kumar S,
Noonan S, Handler C, Kuznetsov A, Shih J, Tran AD, Salomon DS, et
al: TIMP-2 suppresses tumor growth and metastasis in murine model
of triple-negative breast cancer. Carcinogenesis. 41:313–325. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Afonja O, Juste D, Das S, Matsuhashi S and
Samuels HH: Induction of PDCD4 tumor suppressor gene expression by
RAR agonists, antiestrogen and HER-2/neu antagonist in breast
cancer cells. Evidence for a role in apoptosis. Oncogene.
23:8135–8145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hwang SK, Jeong YJ and Chang Y-C: PDCD4
inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling
pathway and upregulating Keap1 expression. Am J Cancer Res.
10:424–439. 2020.PubMed/NCBI
|
